Stage II Prostate Cancer
21
1
3
14
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
9.5%
2 terminated out of 21 trials
87.5%
+1.0% vs benchmark
10%
2 trials in Phase 3/4
50%
7 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (21)
Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer
Researching the Effect of Exercise on Cancer
Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET)
Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer
Acupuncture Pilot Study for Cancer-related Cognitive Function
Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer
Ask Questions (ASQ):Implementation of a Communication Intervention
Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer
Collection of Serum Samples in Studying Emotional Stress in Patients With Prostate Cancer
Visually Enhanced Education About Prostate Cancer
Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer
Genistein in Treating Patients With Prostate Cancer
MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the Prostate
Intensity-Modulated External Beam Radiation Therapy in Treating Patients With Prostate Cancer
ED Recovery in Men Age </=65 Treated With Bilateral Nerve Sparing Robotic Assisted Prostatectomy for Prostate Cancer
Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer
Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer
Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the Prostate
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer